A Clinical Trial to Evaluate the Effects of Super Lungs Liquid Drops on Respiratory Comfort, Airway Soothing, and Overall Well-Being

Running, not enrolling · Not applicable

Conditions studied: Coughing, Throat Irritation

In brief

This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of Super Lungs Liquid Drops on respiratory comfort, airway soothing, and overall well-being in generally healthy adults aged 18-65 who experience bothersome respiratory symptoms. All 35 enrolled participants will receive the active study product and self-administer 2 mL of the drops daily (two full droppers of 1 mL each, once daily with the first meal of the day) for 12 weeks.

Key facts

Study ID

NCT07694284

Run by

SuperBonsai Inc.

People needed

35

Starts

2026-07-02

Expected to finish

2026-08-01

Last updated by the study team

2026-07-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 18-65 years.
• Over the past two months, has experienced bothersome coughing on a weekly basis.
• Anyone who has experienced issues with at least two of the following over the past four weeks: chest tightness or congestion; persistent throat irritation or itchiness; excess mucus or phlegm buildup.
• Generally healthy, without any uncontrolled chronic disease.
• Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
• Resides in the United States.
• Has access to the internet and a device (smartphone, tablet, or computer) capable of completing online questionnaires.
• Willing to follow the study protocol and complete all required assessments.

You may not qualify if…

• Anyone with a known allergy or sensitivity to any of the study product ingredients.
• Anyone with a known allergy to plants in the Asteraceae/Compositae family.
• Women who are pregnant, breastfeeding, or planning to become pregnant during the study period.
• Anyone currently taking immunosuppressant medications (e.g., cyclosporine, methotrexate, biologics such as adalimumab or infliximab).
• Anyone with a diagnosed autoimmune disorder (e.g., lupus, rheumatoid arthritis, multiple sclerosis).
• Anyone with uncontrolled hypertension or currently taking antihypertensive medications, diuretics, or corticosteroids.
• Anyone currently taking anticoagulant or antiplatelet medications (e.g., warfarin, heparin, clopidogrel).
• Anyone with a chronic health condition that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, a history of substance abuse, or planned surgery during the study period.
• Anyone with a history of alcohol use disorder or currently in alcohol recovery.
• Anyone currently participating in another research study or who plans to participate in another study during the study period. (

Where it is running

• Citruslabs — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.